Osimertinib for Advanced EGFR-positive NSCLC Patients

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Osimertinib for Advanced EGFR-positive NSCLC Patients	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Recruiting	Not stated	2025-09-25		NCT05037331

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National University Hospital, Singapore	120

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
National University Hospital	Singapore	Singapore	46

Clinical trials